BCR-ABL-Expressing Cells Transduced with the HSV-tk Gene Die by Apoptosis upon Treatment with Ganciclovir

This publication has 32 references indexed in Scilit:

• Hematopoietic stem cell transplantation in chronic myeloid leukemia
  Current Opinion in Hematology, 1998
• “Suicide” gene for the control of graft-versus-host disease
  Current Opinion in Hematology, 1998
• Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
  Nature Medicine, 1998
• HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
  Science, 1997
• Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression
  International Journal of Cancer, 1997
• Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir
  Cancer Letters, 1995
• The Treatment of Ovarian Cancer with a Gene Modified Cancer Vaccine: A Phase I Study. Tulane University, New Orleans, Louisiana
  Human Gene Therapy, 1995
• The “Bystander Effect”: Association of U-87 Cell Death with Ganciclovir-Mediated Apoptosis of Nearby Cells and Lack of Effect in Athymic Mice
  Human Gene Therapy, 1995
• BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death [published erratum appears in Blood 1994 Jun 15;83(12):3835]
  Blood, 1994
• Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of Health
  Human Gene Therapy, 1993